Yasmin Nabil Laimon

5PUBLICATIONS
67CO-AUTHORS
Molecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 24, 2026
Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinoma.

|May 18, 2026
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial.

|Aug 20, 2025
Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors.

Shilpa Singh, Catherine E Gleason, Min Fang

|Jan 09, 2025
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.

Tejas Jammihal, Renee Maria Saliby, Chris Labaki

|Aug 17, 2023
KDM6A epigenetically regulates subtype plasticity in small cell lung cancer.

Leslie Duplaquet, Yixiang Li, Matthew A Booker

Pageof 1

Frequent Collaborators

5 joint publications

Sabina Signoretti

3 joint publications

Toni K Choueiri

2 joint publications

Maxwell D Seager

2 joint publications

Eliezer Van Allen